Fertin Pharma

Fertin Pharma is a leading global CDMO with a unique focus on consumer-centric oral delivery systems, blending pharmaceutical efficacy with confectionery science. It operates R&D centers and manufacturing facilities in Denmark, Canada, and India, employing over 1,200 specialists and holding a robust portfolio of more than 500 patents. The company's core business is providing end-to-end services—from R&D and sensory optimization to manufacturing and regulatory support—for clients in the nutraceutical and pharmaceutical sectors, producing over 3.1 billion units annually.

Proprietary oral and intra-oral delivery systems including compressed gum, extruded gum, soft chews, lozenges, Click pouches, and Zapliq® liquefiable tablets. Platform integrates pharmaceutical science with confectionery expertise for efficacy, taste masking, and pleasant mouthfeel.

Fertin competes with large, diversified CDMOs (e.g., Catalent, Lonza) and specialized oral dosage form manufacturers. Its key differentiator is its deep confectionery heritage and focus on sensory optimization, allowing it to compete on superior taste and consumer experience rather than just cost and capacity.